$7.62
0.9614.41%
At close: -
$7.20
-0.42-5.51%
After Hours: Jan 3, 8:54 AM EDT
Comments
Loading...
Lifecore Biomedical (LFCR) Forecast
NewsEarningsLifecore Biomedical (LFCR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLifecore Biomedical (NASDAQ:LFCR) Stock Quotes, Forecast and News Summary
Lifecore Biomedical Stock (NASDAQ: LFCR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lifecore Biomedical (LFCR) stock?
You can purchase shares of Lifecore Biomedical (NASDAQ:LFCR) through any online brokerage.
Who are Lifecore Biomedical (LFCR) competitors?
Other companies in Lifecore Biomedical’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), CryoPort (NASDAQ:CYRX), Mesa Laboratories (NASDAQ:MLAB) and Personalis (NASDAQ:PSNL).
What is the forecast, or price target, for Lifecore Biomedical (LFCR) stock?
Lifecore Biomedical has a consensus price target of $8.00.
What is the current price for Lifecore Biomedical (LFCR)?
The stock price for Lifecore Biomedical (NASDAQ: LFCR) is $7.2 last updated January 3, 2025 at 8:54 AM EST.
Does Lifecore Biomedical (LFCR) pay a dividend?
There are no upcoming dividends for Lifecore Biomedical.
When is Lifecore Biomedical (NASDAQ:LFCR) reporting earnings?
Lifecore Biomedical’s Q2 earnings are confirmed for Thursday, January 2, 2025.
Is Lifecore Biomedical (LFCR) going to split?
There is no upcoming split for Lifecore Biomedical.
What sector and industry does Lifecore Biomedical (LFCR) operate in?
Lifecore Biomedical is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.